James A. Gallagher

4.0k total citations
103 papers, 2.8k citations indexed

About

James A. Gallagher is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, James A. Gallagher has authored 103 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 45 papers in Clinical Biochemistry and 21 papers in Oncology. Recurrent topics in James A. Gallagher's work include Metabolism and Genetic Disorders (45 papers), Mitochondrial Function and Pathology (20 papers) and Bone health and treatments (19 papers). James A. Gallagher is often cited by papers focused on Metabolism and Genetic Disorders (45 papers), Mitochondrial Function and Pathology (20 papers) and Bone health and treatments (19 papers). James A. Gallagher collaborates with scholars based in United Kingdom, United States and Slovakia. James A. Gallagher's co-authors include L. Ranganath, Jonathan C. Jarvis, W.B. Bowler, William D. Fraser, Katherine M. Buckley, Peter J. Wilson, Alison Gartland, J.P. Dillon, Graham R. Sharpe and Nathan Jeffery and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

James A. Gallagher

103 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Gallagher United Kingdom 35 1.2k 701 530 467 327 103 2.8k
Willy Lissens Belgium 43 3.3k 2.7× 987 1.4× 50 0.1× 326 0.7× 410 1.3× 235 7.0k
Stefania Petrini Italy 34 2.2k 1.8× 140 0.2× 47 0.1× 353 0.8× 139 0.4× 127 3.7k
Maja Di Rocco Italy 34 1.5k 1.2× 254 0.4× 111 0.2× 305 0.7× 77 0.2× 147 3.6k
Paige Kaplan United States 42 1.6k 1.3× 665 0.9× 117 0.2× 109 0.2× 97 0.3× 135 5.7k
Bridget E. Bax United Kingdom 29 1.1k 0.8× 208 0.3× 52 0.1× 192 0.4× 38 0.1× 69 2.2k
Mathias Mericskay France 32 2.6k 2.1× 73 0.1× 181 0.3× 376 0.8× 36 0.1× 65 4.3k
Virginia Nunes Spain 42 2.1k 1.7× 858 1.2× 79 0.1× 196 0.4× 1.1k 3.4× 137 4.8k
Li Sun United States 38 2.3k 1.9× 117 0.2× 160 0.3× 825 1.8× 43 0.1× 85 4.7k
R. Tyler Miller United States 38 2.6k 2.1× 78 0.1× 50 0.1× 263 0.6× 167 0.5× 85 4.3k
Wim J. Kleijer Netherlands 39 3.6k 2.9× 445 0.6× 126 0.2× 381 0.8× 171 0.5× 137 7.0k

Countries citing papers authored by James A. Gallagher

Since Specialization
Citations

This map shows the geographic impact of James A. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Gallagher more than expected).

Fields of papers citing papers by James A. Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Gallagher. The network helps show where James A. Gallagher may publish in the future.

Co-authorship network of co-authors of James A. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Gallagher. A scholar is included among the top collaborators of James A. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Gallagher. James A. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Elinor, David M. Hughes, J. Baker, et al.. (2025). Urinary metabolite model to predict the dying process in lung cancer patients. Communications Medicine. 5(1). 49–49. 1 indexed citations
2.
Ooi, Nicola, Brendan P. Norman, James A. Gallagher, et al.. (2023). Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial. Cells. 12(13). 1683–1683. 1 indexed citations
3.
Marcélis, Lionel, Georges Casimir, Philippe Goyens, et al.. (2023). Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Genes. 14(3). 693–693. 3 indexed citations
4.
Ranganath, L., Milad Khedr, Anna M. Milan, et al.. (2023). Increased prevalence of Parkinson's disease in alkaptonuria. JIMD Reports. 64(4). 282–292. 3 indexed citations
5.
Genovese, Federica, Peder Frederiksen, Anne‐Christine Bay‐Jensen, et al.. (2023). Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients. International Journal of Molecular Sciences. 24(13). 10996–10996. 3 indexed citations
6.
Gallagher, James A., J.P. Dillon, Nicolas Sireau, Oliver Timmis, & L. Ranganath. (2016). Alkaptonuria: An example of a “fundamental disease”—A rare disease with important lessons for more common disorders. Seminars in Cell and Developmental Biology. 52. 53–57. 26 indexed citations
7.
Sutherland, Hazel, Peter J. Wilson, Eftychia Eirini Psarelli, et al.. (2015). Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice. JIMD Reports. 24. 45–50. 37 indexed citations
8.
Pacheco‐Pantoja, Elda, et al.. (2013). Adiponectin receptors are present in RANK-L-induced multinucleated osteoclast-like cells. Journal of Receptors and Signal Transduction. 33(5). 291–297. 14 indexed citations
9.
Sutherland, Hazel, Peter J. Wilson, B Wlodarski, et al.. (2013). Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Annals of the Rheumatic Diseases. 73(1). 284–289. 72 indexed citations
10.
Gallagher, James A., Adam Taylor, A. Boyde, Jonathan C. Jarvis, & L. Ranganath. (2012). Recent advances in understanding the pathogenesis of ochronosis. Reumatologia/Rheumatology. 50(4). 316–323. 3 indexed citations
11.
Gartland, Alison, Robin M. H. Rumney, J.P. Dillon, & James A. Gallagher. (2011). Isolation and Culture of Human Osteoblasts. Methods in molecular biology. 806. 337–355. 40 indexed citations
12.
Rumney, Robin M. H., et al.. (2008). The effect of ATP, alone and in combination with EGF, on breast cancer cell survival. ePrints Soton (University of Southampton). 1 indexed citations
13.
Buckley, Katherine M., et al.. (2004). Human Osteoclast Culture From Peripheral Blood Monocytes: Phenotypic Characterization and Quantitation of Resorption. Humana Press eBooks. 107. 55–68. 16 indexed citations
14.
Gallagher, James A., et al.. (2003). The isolation of Osteoclasts from Human Giant Cell Tumors and Long-Term Marrow Cultures. Humana Press eBooks. 2. 263–276. 4 indexed citations
15.
Bowler, W.B., et al.. (2003). Human Keratinocytes Express Multiple P2Y-Receptors: Evidence for Functional P2Y1, P2Y2, and P2Y4 Receptors. Journal of Investigative Dermatology. 120(3). 440–447. 61 indexed citations
16.
Buckley, Katherine M., Simon C. Wagstaff, A. Gaw, et al.. (2001). Parathyroid Hormone Potentiates Nucleotide-induced [Ca2+] Release in Rat Osteoblasts Independently of Gq Activation or Cyclic Monophosphate Accumulation. Journal of Biological Chemistry. 276(12). 9565–9571. 61 indexed citations
17.
Gallagher, James A., Yolanda C. Oertel, & James E. Oertel. (1997). Follicular variant of papillary carcinoma of the thyroid: Fine-needle aspirates with histologic correlation. Diagnostic Cytopathology. 16(3). 207–213. 52 indexed citations
18.
Burtis, William J., et al.. (1995). Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: evidence for growth-inhibiting and invasion-promoting effects. Molecular and Cellular Endocrinology. 111(2). 225–232. 59 indexed citations
19.
Gallagher, James A., et al.. (1992). The OSU Heat Release Unit as a Screening Tool for California TB 133. Journal of Fire Sciences. 10(3). 243–259. 2 indexed citations
20.
Winston, Drew J., L J Eron, Monto Ho, et al.. (1988). Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer. The American Journal of Medicine. 85(2). 147–151. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willy Lissens Breakdown of academic impact, for papers by Stefania Petrini Breakdown of academic impact, for papers by Maja Di Rocco Breakdown of academic impact, for papers by Paige Kaplan Breakdown of academic impact, for papers by Bridget E. Bax Breakdown of academic impact, for papers by Mathias Mericskay Breakdown of academic impact, for papers by Virginia Nunes Breakdown of academic impact, for papers by Li Sun Breakdown of academic impact, for papers by R. Tyler Miller Breakdown of academic impact, for papers by Wim J. Kleijer
Rankless by CCL
2026